Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Michelson Diagnostics appoints head of new US subsidiary

This article was originally published in Clinica

Executive Summary

UK skin cancer imaging firm Michelson Diagnostics has appointed Karen Miller Gillis as vice-president of sales and marketing and general manager of its new US subsidiary in Massachusetts. Ms Gillis has 16 years' sales experience in the medtech industry; she was most recently with surgical products company Mpathy Medical Devices (which was acquired by Coloplast in October 2010) and prior to that, with retina scanner firm Optos. Ms Gillis joins Michelson as the company expands commercialisation of its VivoSight optical coherence tomography (OCT) scanner outside the UK. The device, which allows dermatologists to see up to 2mm below the surface of the patient's skin and improve diagnosis of skin cancer, was cleared by the US FDA in January last year (www.clinica.co.uk, 22 January 2010).

You may also be interested in...



Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.

Topics

UsernamePublicRestriction

Register

MT097609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel